Keros Therapeutics (KROS) Shares Outstanding (Diluted) (2020 - 2026)
Keros Therapeutics' Shares Outstanding (Diluted) was 19.8 million in Q2 2026, down 51.2% from 40.61 million a year earlier.
Powered by 
Analysis
Keros Therapeutics (KROS) Shares Outstanding (Diluted) (2020 - 2026) Analysis & Trends
For FY2025, Shares Outstanding (Diluted) at Keros Therapeutics came in at 37.86 million, up 1.1% from FY2024.
- Shares Outstanding (Diluted) has now increased for five consecutive years, with a five-year compound annual growth rate of 19.5% (FY2020 to FY2025).
- In earlier years, Shares Outstanding (Diluted) was 37.44 million in FY2024 (+27.1%), 29.45 million in FY2023 (+16.7%), 25.24 million in FY2022 (+8.2%) and 23.33 million in FY2021 (+50.5%).
- The Q2 2026 figure marks the lowest quarterly Shares Outstanding (Diluted) since Q4 2020.
- Compared with a year earlier, Shares Outstanding (Diluted) was higher in six of the last seven quarters, with growth averaging 5.6%.
- The best year-over-year quarter for Shares Outstanding (Diluted) over five years was Q4 2021 (growth of 50.5%); the worst was Q2 2026 (a decline of 51.2%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,144.40 Bn | 1,112.99 Bn | 19.71 Bn | 893.70 Mn |
| 2 | Johnson & Johnson | 634.88 Bn | 554.74 Bn | 17.30 Bn | 2.45 Bn |
| 3 | AbbVie | 500.40 Bn | 473.51 Bn | 12.70 Bn | 1.77 Bn |
| 4 | Merck | 356.05 Bn | 310.43 Bn | 12.21 Bn | 2.47 Bn |
| 5 | Novartis Ag | 301.50 Bn | 265.49 Bn | 11.24 Bn | 1.96 Bn |
| 6 | Astrazeneca | 264.72 Bn | 238.40 Bn | 12.86 Bn | 1.56 Bn |
| 7 | Amgen | 238.14 Bn | 193.54 Bn | 7.24 Bn | 544.00 Mn |
| 8 | Gilead Sciences | 195.19 Bn | 169.39 Bn | 6.22 Bn | 1.24 Bn |
| 9 | Pfizer | 171.40 Bn | 118.04 Bn | 10.94 Bn | 5.70 Bn |
| 10 | Keros Therapeutics | 223.55 Mn | -1.71 Bn | - | 19.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 19.80 Mn |
| Dec 31, 2025 | 37.86 Mn |
| Sep 30, 2025 | 40.62 Mn |
| Jun 30, 2025 | 40.61 Mn |
| Mar 31, 2025 | 41.02 Mn |
| Dec 31, 2024 | 37.44 Mn |
| Sep 30, 2024 | 37.59 Mn |
| Jun 30, 2024 | 36.10 Mn |
| Mar 31, 2024 | 35.69 Mn |
| Dec 31, 2023 | 29.45 Mn |
| Sep 30, 2023 | 29.67 Mn |
| Jun 30, 2023 | 29.60 Mn |
| Mar 31, 2023 | 28.37 Mn |
| Dec 31, 2022 | 25.24 Mn |
| Sep 30, 2022 | 25.55 Mn |
| Jun 30, 2022 | 24.05 Mn |
| Mar 31, 2022 | 23.99 Mn |
| Dec 31, 2021 | 23.33 Mn |
| Sep 30, 2021 | 23.36 Mn |
| Jun 30, 2021 | 23.31 Mn |
API Access
Keros Therapeutics Shares Outstanding (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=KROS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-diluted", "ticker": "KROS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=KROS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();